NCCN 2012 Congress Webinar Series: Gastrointestinal Cancers™: Adjuvant Treatment for Colorectal Cancer
This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Colorectal, Hepatocellular, Pancreatic, and Gastric/Esophageal Cancers. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. This series will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.
This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Discuss the role of adjuvant therapy for stage II colon cancer
- List the factors that identify patients with stage II colon cancer who may benefit from adjuvant therapy
- Describe the recent studies that compare the efficacies of the various adjuvant treatments
- Discuss the toxicity profiles of available chemotherapy regimens
Emily Chan, MD, PhD
Vanderbilt-Ingram Cancer Center
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician